1,6-Hexanediol

1,6-Hexanediol

SCHEMBL998036

O=C(O)CCS.O=C(O)CCS.OCCCCCCO

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 3/20 0.67
FFAR1 O14842 1/20 0.67
FFAR4 Q5NUL3 1/20 0.67
CAMK2A Q9UQM7 1/20 0.57
FOLH1 Q04609 4/20 0.52
ACE P12821 1/20 0.50
LMNA P02545 3/20 0.48
TSHR P16473 2/20 0.48
NFKB1 P19838 1/20 0.48
PMP22 Q01453 1/20 0.48
FNTA P49354 1/20 0.45
FNTB P49356 1/20 0.45
SLC22A6 Q4U2R8 2/20 0.43
GSTK1 Q9Y2Q3 1/20 0.40
ALKBH5 Q6P6C2 1/20 0.40
SUCNR1 Q9BXA5 1/20 0.40
EGLN1 Q9GZT9 1/20 0.40
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
PPARG P37231 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1,5-Pentanediol SCHEMBL29088658 1.00 GPR84 (0.67) GPR84FFAR1FFAR4CAMK2AFOLH1
Mercaptopropionic Acid SCHEMBL15379275 1.00 GPR84 (0.67) GPR84FFAR1FFAR4CAMK2AFOLH1
Mercaptopropionic Acid SCHEMBL15380254 1.00 GPR84 (0.67) GPR84FFAR1FFAR4CAMK2AFOLH1
Mercaptopropionic Acid SCHEMBL552238 0.97 GPR84 (0.62) GPR84FFAR1FFAR4CAMK2AFOLH1
Mercaptopropionic Acid SCHEMBL25301983 0.92 FOLH1 (0.64) GPR84FFAR1FFAR4CAMK2AFOLH1
Mercaptopropionic Acid SCHEMBL997923 0.92 CAMK2A (0.60) GPR84FFAR1FFAR4CAMK2AFOLH1
Octacosanol SCHEMBL29285284 0.89 GPR84 (0.58) GPR84FFAR1FFAR4LMNATSHR
Mercaptopropionic Acid SCHEMBL28714218 0.86 ACE (0.57) GPR84FFAR1FFAR4CAMK2AFOLH1
Mercaptopropionic Acid SCHEMBL30556234 0.86 ACE (0.57) GPR84FFAR1FFAR4CAMK2AFOLH1
Mercaptopropionic Acid SCHEMBL2227412 0.86 ACE (0.57) GPR84FFAR1FFAR4CAMK2AFOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024218251-A1 POLYMER DISPERSIONS OF POLYMERS P BASF SE (DE) 2024-10-24 WO claimed
CN-113956477-B Curing composition and application thereof, and cured polymer material and preparation method and application thereof 中国石油化工股份有限公司 2023-10-13 CN claimed
US-20260140398-A1 OPTICAL MATERIAL COMPOSITION, CURED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES TOKUYAMA CORPORATION (JP) 2026-05-21 US disclosed
US-12552745-B2 Compound for optical materials, curable composition, cured body, and optical article TOKUYAMA CORPORATION (JP) 2026-02-17 US disclosed
EP-4667545-A1 PHOTOCURABLE COMPOSITION Bostik SA (FR) 2025-12-24 EP disclosed
EP-4667546-A1 PHOTOCURABLE COMPOSITION Bostik SA (FR) 2025-12-24 EP disclosed
US-12503575-B2 Fine hollow particles comprising melamine-based resin KAGOSHIMA UNIVERSITY (JP) 2025-12-23 US disclosed
US-12492293-B2 Multi-component systems for preparing foamed products ARKEMA FRANCE (FR) 2025-12-09 US disclosed
EP-4603522-A1 OPTICAL MATERIAL COMPOSITION, CURED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES TOKUYAMA CORPORATION (JP) 2025-08-20 EP disclosed
WO-2025125082-A1 POLYMERIZABLE PHOSPHINE OXIDE-BASED PHOTOINITIATORS ARKEMA FRANCE (FR) 2025-06-19 WO disclosed
EP-4570811-A1 POLYMERIZABLE PHOSPHINE OXIDE-BASED PHOTOINITIATORS ARKEMA FRANCE (FR) 2025-06-18 EP disclosed
EP-3330751-A1 PHOTOCHROMIC COATING COMPOSITION Tokuyama Corporation (JP) 2018-06-06 EP disclosed
US-20180030341-A1 PROCESS FOR PRODUCING A PHOTOCHROMIC CURED BODY TOKUYAMA CORPORATION (JP) 2018-02-01 US disclosed
EP-3269774-A1 METHOD FOR PRODUCING PHOTOCHROMIC CURED BODY Tokuyama Corporation (JP) 2018-01-17 EP disclosed
US-20150080509-A1 PHOTOCURABLE MATERIAL FOR SEALING, SEALING METHOD, SEALING MATERIAL, AND HOUSING USING SAID SEALING MATERIAL NITTA GELATIN KK (JP) 2015-03-19 US disclosed
US-8921446-B2 Photocurable material for sealing, sealing method, sealing material, and housing using said sealing material NITTA GELATIN INC. (JP) 2014-12-30 US disclosed
US-20130303651-A1 PHOTOCURABLE MATERIAL FOR SEALING, SEALING METHOD, SEALING MATERIAL, AND HOUSING USING SAID SEALING MATERIAL BOSTIK SA (FR) 2013-11-14 US disclosed
EP-2258780-B1 PRIMER COMPOSITION MITSUI CHEMICALS INC (JP) 2012-09-26 EP disclosed
US-20110014483-A1 PRIMER COMPOSITION MITSUI CHEMICALS, INC. 2011-01-20 US disclosed
EP-2258780-A1 PRIMER COMPOSITION Mitsui Chemicals, Inc. (JP) 2010-12-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12552745-B2 Compound for optical materials, curable composition, cured body, and optical article C5, SCO2, ZYX GPR84 2970/4885FFAR1 763/4885FFAR4 775/4885
US-20260140398-A1 OPTICAL MATERIAL COMPOSITION, CURED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES CRYAA, FEM1B, MAPRE1 GPR84 4055/4885FFAR1 1925/4885FFAR4 3653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.